Aspire Growth Partners’s Cigna CI Stock Holding History

Aspire Growth Partners’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-624	Closed	-$206K	–	119
2025 Q2	$206K	Sell	624 -131	-17%	-$42.2K	0.17%	113
2025 Q1	$253K	Buy	+755	New	+$227K	0.22%	97

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aspire Growth Partners's CI Position: Q3 2025 in Review

Aspire Growth Partners sold out of Cigna (CI) in Q3 2025, closing a stake of 624 shares — an estimated $206K sold.

Aspire Growth Partners first reported a position in CI in Q1 2025 and held it in 2 quarters. The position peaked at $253K in Q1 2025. 1,613 funds tracked by Wall St. Rank hold CI as of Q3 2025.

Aspire Growth Partners reported no remaining Cigna position as of Q3 2025 after selling out during the quarter.
Aspire Growth Partners sold 624 Cigna shares in Q3 2025, an estimated $206K.
Aspire Growth Partners first reported a position in Cigna in Q1 2025 and held it in 2 quarters.
Aspire Growth Partners's Cigna position peaked at $253K in Q1 2025.
1,613 funds tracked by Wall St. Rank held Cigna as of Q3 2025.

Based on Aspire Growth Partners's 13F filing for Q3 2025, filed 3 Nov 2025.